NMPA Approval

Rosiglitazone Hydrochloride Tablets

Approval Number

国药准字H20080256

Company浙江海正药业股份有限公司

Registration Date

November 14, 2022

Previous Approval Numbers

国药准字H20080256

Drug Information

Generic Name

盐酸罗格列酮片

Brand Name

内美通

Dosage Form

片剂

Strength

以C18H19N3O3S计 2mg

Drug Type

化学药品

Registration Date

November 14, 2022

Company Information

Applicant Company

Company Name浙江海正药业股份有限公司

Company Address

浙江省台州市椒江区外沙路46号

Manufacturing Company

Company Name浙江海正药业股份有限公司

Company Address

浙江省台州市椒江区海正大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸罗格列酮片 - NMPA 批准文号 | MedPath